Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-04-04 Sale |
2023-04-06 4:37 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director |
39,228 | $1.85 | $72,572 | 188,779 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 8:32 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
45,070 | $1.111 | $50,075 | 228,007 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-11 8:57 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
37,294 | $6.883 | $256,696 | 185,577 (Direct) |
View |
| 2021-01-21 Sale |
2021-01-25 5:38 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $12.06 | $404,227 | 805,540 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-20 8:38 pm |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $9.6927 | $838,243 | 2,309,396 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-11 06:21 am |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
21,999 | $6.8889 | $151,549 | 140,371 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-05-03 Equity Swap |
2023-05-04 07:44 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD Director |
188,778 | $0 | 1 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 7:37 pm |
N/A 2032-02-01 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
262,500 | $0 | 448,077 (Direct) |
View |
| 2021-02-01 Option Award |
2021-02-03 5:48 pm |
N/A 2031-02-01 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
247,500 | $0 | 387,871 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:38 pm |
N/A 2024-06-26 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $0 | 805,540 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-25 5:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
33,518 | $0.48 | 805,540 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 8:38 pm |
N/A 2024-06-26 |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $0 | 2,309,396 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 8:38 pm |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | MURRAY RICHARD CEO and President |
86,482 | $0.48 | 2,309,396 (Direct) |
View |